60 related articles for article (PubMed ID: 8528889)
1. Cyclosporin A inhibits interleukin-2-induced release of corticotropin-releasing hormone.
Karanth S; Lyson K; McCann SM
Neuroimmunomodulation; 1994 Jan; 1(1):82-5. PubMed ID: 8528889
[TBL] [Abstract][Full Text] [Related]
2. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus.
Karanth S; Lyson K; McCann SM
Neuroimmunomodulation; 1999; 6(3):168-74. PubMed ID: 10213914
[TBL] [Abstract][Full Text] [Related]
3. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.
Karanth S; Lyson K; McCann SM
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3383-7. PubMed ID: 8475085
[TBL] [Abstract][Full Text] [Related]
4. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release.
Karanth S; Lyson K; Aguila MC; McCann SM
Neuroimmunomodulation; 1995; 2(3):166-73. PubMed ID: 8646567
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and interleukin-1beta mediate noradrenergic induced corticotrophin-releasing hormone release in organotypic cultures of rat paraventricular nucleus.
Hsieh CH; Li HY; Chen JC
Neuroscience; 2010 Feb; 165(4):1191-202. PubMed ID: 20004705
[TBL] [Abstract][Full Text] [Related]
6. Rat strains that differ in corticotropin-releasing hormone production exhibit different sleep-wake responses to interleukin 1.
Opp MR; Imeri L
Neuroendocrinology; 2001 Apr; 73(4):272-84. PubMed ID: 11340341
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus.
Tringali G; Aubry JM; Navarra P; Pozzoli G
Psychopharmacology (Berl); 2006 Oct; 188(3):386-92. PubMed ID: 16947017
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
Raber J; Koob GF; Bloom FE
J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
[TBL] [Abstract][Full Text] [Related]
9. Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro.
Lyson K; McCann SM
Neuroendocrinology; 1992 Jun; 55(6):708-13. PubMed ID: 1630586
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro.
Roe CM; Leitch IM; Boura AL; Smith R
J Clin Endocrinol Metab; 1996 Feb; 81(2):763-9. PubMed ID: 8636301
[TBL] [Abstract][Full Text] [Related]
11. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway.
Navarra P; Tsagarakis S; Faria MS; Rees LH; Besser GM; Grossman AB
Endocrinology; 1991 Jan; 128(1):37-44. PubMed ID: 1846105
[TBL] [Abstract][Full Text] [Related]
12. Mirtazapine acutely inhibits basal and K(+)-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism.
Fabricio AS; Tringali G; Pozzoli G; Navarra P
Psychopharmacology (Berl); 2005 Feb; 178(1):78-82. PubMed ID: 15300357
[TBL] [Abstract][Full Text] [Related]
13. Blockade by interleukin-1-alpha of nitricoxidergic control of luteinizing hormone-releasing hormone release in vivo and in vitro.
Rettori V; Belova N; Kamat A; Lyson K; Gimeno M; McCann SM
Neuroimmunomodulation; 1994 Jan; 1(1):86-91. PubMed ID: 8528890
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
Nelson PA; Akselband Y; Kawamura A; Su M; Tung RD; Rich DH; Kishore V; Rosborough SL; DeCenzo MT; Livingston DJ
J Immunol; 1993 Mar; 150(6):2139-47. PubMed ID: 7680683
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide controls the hypothalamic-pituitary response to cytokines.
McCann SM; Kimura M; Karanth S; Yu WH; Rettori V
Neuroimmunomodulation; 1997; 4(2):98-106. PubMed ID: 9483201
[TBL] [Abstract][Full Text] [Related]
16. A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins.
Burns G; Almeida OF; Passarelli F; Herz A
Endocrinology; 1989 Sep; 125(3):1365-72. PubMed ID: 2527150
[TBL] [Abstract][Full Text] [Related]
17. Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain.
Tringali G; Lisi L; De Simone ML; Aubry JM; Preziosi P; Pozzoli G; Navarra P
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1017-21. PubMed ID: 19467289
[TBL] [Abstract][Full Text] [Related]
18. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
Bugajski J; Borycz J; Gadek-Michalska A; Głód R
J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
[TBL] [Abstract][Full Text] [Related]
20. Alpha-melanocyte-stimulating hormone inhibits corticotropin-releasing factor release by blocking protein kinase C.
Lyson K; McCann SM
Neuroimmunomodulation; 1994; 1(3):153-8. PubMed ID: 7489328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
